Navigation Links
Angiotech and Symphony Medical Announce Licensing Agreement

cal and clinical development of our products; the ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; decisions, and the timing of decisions, made by health regulatory agencies regarding approval of our technology and products; the ability to complete and maintain corporate alliances relating to the development and commercialization of our technology and products; market acceptance of our technology and products; the competitive environment and impact of technological change; and the continued availability of capital to finance our activities. Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this report to reflect future results, events or developments.


(1) Description and statistics taken from Canadian Association of Cardiac

Rehabilitation website found at:; Paus Jenssen,

L. Erik, Atrial Fibrillation Following Coronary Artery Bypass Grafting.

Canadian Association of Cardiac Rehabilitation (CACR) newsletter:

(2) Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE,

Henderson WG, et al. Atrial fibrillation after cardiac surgery: a major

morbid event? Ann Surg 1997;226:501-11.

(3) Aranski SF, ShawDP, Adams DH, Rizzo RJ, Couper GS, VanderVliet

M. Predictors of atrial fibrillation after coronary artery surgery.

Current trends and impact on hospital resources.

Circulation 1996;94:390-7.

CONTACT: Angiotech Contacts: Jodi Regts, Angiotech Pharmaceuticals, Inc., (6

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
2. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
3. Angiotech to participate in RBC 2007 Healthcare Conference
4. Angiotech to participate in Bank of America 2007 Credit Conference
5. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
8. Angiotech to participate in UBS Global Life Sciences Conference
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/15/2014)... January 15, 2014 AudioNotch is the ... therapy for the treatment of tinnitus. Patients listen to ... and over a period of weeks to months, their tinnitus ... in two forms: Notched Music and Notched White Noise. Now, ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 ... Almshouse Road, Warrington, Pa. , Details: The Hepatitis ... finding a cure for hepatitis B and improving the quality ... Crystal Ball on Friday, April 11 at Warrington Country Club ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Distance learning is about more than just doing the ... Schrage. Rather, technology is a medium that opens up ... is taught, and what the relationship should be between ... research associate at MIT Media Lab and co-director of ...
... Foundation has awarded $1.6 million in federal research funding ... data encryption and privacy safeguards in public health information ... data mining strategies that could still preserve privacy. The ... and Family Services and the Public Health Information Network ...
... A new 75,000-square-foot facility in the Dodge Industrial Park here ... company. , ,The company, API Inc., built the ... two offices that were in separate locations in Hartford. It ... gives the company, formerly known as Automated Peripherals Inc., more ...
Cached Biology Technology:Schrage: Don't think of distance learning as just automation 2Schrage: Don't think of distance learning as just automation 3UW-Madison gets $1.6 million to develop medical privacy safeguards 2
(Date:4/23/2014)... who have had a stroke, often suffer motor deficits ... study conducted in Taiwan, that will be published in ... is currently freely available on-line as an unedited early ... one group of stroke victims had their own peripheral ... and a similar group did not, those who received ...
(Date:4/23/2014)... in Buenos Aires yesterday, Argentina joins the European ... state. The move strengthens the ties between the ... grants Argentinian scientists access to EMBL,s world-class facilities ... "Ever since its inception, fostering excellent life science ... the core of EMBL,s mission," says EMBL Director ...
(Date:4/23/2014)... date of the family of bacteria that causes ... and reveals surprising findings about the bacteria,s origin ... health strategies to control this respiratory disease, which ... analysis of 343 strains of the Bordetella ... over the last 100 years illustrates how vaccination ...
Breaking Biology News(10 mins):Autologous stem cell therapy improves motor function in chronic stroke victims 2Impact of whooping cough vaccination revealed 2
... Due to the introduction of exotic pests and pathogens, ... forest ecosystems. In some cases, scientists can observe immediately ... cases, creative puzzle solving and analysis reveal unexpected repercussions. ... hemlock tree, University of Illinois landscape and ecosystem ecologist ...
... Keoladeo National Park in northwest India, one thing was hard for ... the jackals. It was the squawks of peacocks in the throes ... she could hear a loud two-part whoop, the distinctive call that ... dance, a male announces that he,s ready to make his move ...
... third-year graduate student at the Icahn School of Medicine at ... Forbes "30 Under 30" list in "Science and Health." ... is transforming for the better, opening up to revolutionary new ... Forbes . Ms. Shapiro, 25, a native of Rochester, ...
Cached Biology News:Death of hemlock trees yields new life for hardwood trees, but at what cost to the ecosystem? 2Death of hemlock trees yields new life for hardwood trees, but at what cost to the ecosystem? 3Peacock love songs lure eavesdropping females from afar 2Mount Sinai grad student, 25, named to Forbes '30 Under 30' in Science and Healthcare 2
... SeMet White to off-white solid. Increases the ... HPLC. Soluble in H 2 O. ... use. RTECS EK7713840, CAS 3211-76-5, M.W. 196.1. ... 8515.Jornot, L., and Junod, A.F. 1995. ...
... pen has been designed to provide a thin film-like ... on a slide. This barrier creates the proper ... target area on the slide. PAP Pen contains ... acetone. It can be removed, if desired, by ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Biology Products: